These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24926416)

  • 1. The impact of Medicaid peer support utilization on cost.
    Landers G; Zhou M
    Medicare Medicaid Res Rev; 2014; 4(1):. PubMed ID: 24926416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effectiveness of a Peer-Staffed Crisis Respite Program as an Alternative to Hospitalization.
    Bouchery EE; Barna M; Babalola E; Friend D; Brown JD; Blyler C; Ireys HT
    Psychiatr Serv; 2018 Oct; 69(10):1069-1074. PubMed ID: 30071793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of relationships among peer support, psychiatric hospitalization, and crisis stabilization.
    Landers GM; Zhou M
    Community Ment Health J; 2011 Feb; 47(1):106-12. PubMed ID: 19551502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of independent housing for the chronically mentally ill: do housing and neighborhood features matter?
    Harkness J; Newman SJ; Salkever D
    Health Serv Res; 2004 Oct; 39(5):1341-60. PubMed ID: 15333112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Impacts of the Patient Care Networks of Alabama Initiative.
    Bronstein JM; Morrisey MA; Sen B; Engler S; Smith WK
    Health Serv Res; 2016 Feb; 51(1):146-66. PubMed ID: 26058985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antipsychotic medication on psychiatric service utilization and cost.
    Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
    J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC; Marcoux RM; Quilliam BJ
    J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost shifting in a mental health carve-out for the AFDC population.
    Norton EC; Lindrooth RC; Dickey B
    Health Care Financ Rev; 1997; 18(3):95-108. PubMed ID: 10170356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capitation of public mental health services in Colorado: a five-year follow-up of system-level effects.
    Bloom JR; Wang H; Kang SH; Wallace NT; Hyun JK; Hu TW
    Psychiatr Serv; 2011 Feb; 62(2):179-85. PubMed ID: 21285096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicaid managed care and the distribution of societal costs for persons with severe mental illness.
    Shern DL; Jones K; Chen HJ; Jordan N; Ramoni-Perazzi J; Boothroyd RA
    Am J Psychiatry; 2008 Feb; 165(2):254-60. PubMed ID: 18198269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public expenditures related to the criminal justice system and to services for arrestees with a serious mental illness.
    Petrila J; Andel R; Constantine R; Robst J
    Psychiatr Serv; 2010 May; 61(5):516-9. PubMed ID: 20439375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental health care utilization and expenditures by children in foster care.
    Harman JS; Childs GE; Kelleher KJ
    Arch Pediatr Adolesc Med; 2000 Nov; 154(11):1114-7. PubMed ID: 11074852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care.
    Dickey B; Azeni H
    Am J Public Health; 1996 Jul; 86(7):973-7. PubMed ID: 8669521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicaid expenditures on behavioral health care.
    Mark TL; Buck JA; Dilonardo JD; Coffey RM; Chalk M
    Psychiatr Serv; 2003 Feb; 54(2):188-94. PubMed ID: 12556599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peer support for people with severe mental illness versus usual care in high-, middle- and low-income countries: study protocol for a pragmatic, multicentre, randomised controlled trial (UPSIDES-RCT).
    Moran GS; Kalha J; Mueller-Stierlin AS; Kilian R; Krumm S; Slade M; Charles A; Mahlke C; Nixdorf R; Basangwa D; Nakku J; Mpango R; Ryan G; Shamba D; Ramesh M; Ngakongwa F; Grayzman A; Pathare S; Mayer B; Puschner B
    Trials; 2020 May; 21(1):371. PubMed ID: 32357903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.
    Soumerai SB; McLaughlin TJ; Ross-Degnan D; Casteris CS; Bollini P
    N Engl J Med; 1994 Sep; 331(10):650-5. PubMed ID: 8052275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migration, mental health and costs consequences in Romania.
    Miclutia I; Junjan V; Popescu CA; Tigan S
    J Ment Health Policy Econ; 2007 Mar; 10(1):43-50. PubMed ID: 17417046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Pay for Success" Financing and Home-Based Multicomponent Childhood Asthma Interventions: Modeling Results From the Detroit Medicaid Population.
    Lantz PM; Miller G; Rhyan CN; Rosenbaum S; Ku L; Iovan S
    Milbank Q; 2018 Jun; 96(2):272-299. PubMed ID: 29870111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of the effects of financial risk on the formal treatment costs for a Medicaid population with psychiatric disabilities.
    Jones K; Chen HJ; Jordan N; Boothroyd RA; Ramoni-Perazzi J; Shern DL
    Med Care; 2006 Apr; 44(4):320-7. PubMed ID: 16565632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.